CT Angiography Diagnose CAD In Hodgkin's Survivors | Cardiology
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Specialities Cardiology CT Angiography Diagnose CAD In Hodgkin's Survivors

CT Angiography Diagnose CAD In Hodgkin's Survivors

Specialties - Cardiology

CT angiography is found to be a useful tool to diagnosis coronary artery abnormality in survivors of childhood Hodgkin’s lymphoma aged 17 years to 28 years.

Using CT angiography, a significant association was found between mediastinal radiotherapy and the development of a coronary artery abnormality in survivors of childhood Hodgkin’s lymphoma aged 17 years to 28 years, leading researchers to conclude that CT angiography may be a useful tool to diagnosis coronary artery disease in this patient population.

Between January 2007 and December 2008, researchers conducted a prospective study examining 119 patients treated with chemotherapy or radiotherapy who were in remission for longer than two years after completion of therapy. The mean age of patients was 20 years. Of the possible treatments, 92.4% of patients received chemoradiotherapy and 7.6% had chemotherapy alone. Doxorubicin was given to 77.3% of patients and 53.6% received mediastinal radiotherapy.

Coronary abnormalities were found in 16% of patients. There was an association between developing a coronary artery abnormality and having been treated with mediastinal radiotherapy (P=.02). In multivariate analysis, patients who received a dose greater than 20 Gy had a 6.8 times greater risk for developing a coronary artery abnormality than those who received a lesser dose (P=.009).

“Our study demonstrated that the risk of developing coronary artery disease in asymptomatic patients is 16% in the first 10 years,” the researchers wrote. “Although a reduction in radiation doses has been made in recent years clinicians must consider the toxic effect of radiation to the myocard. Radiotherapy protocols should be revised and especially the necessity of mediastinal radiotherapy must be discussed for all newly diagnosed patients with Hodgkin’s lymphoma.”

Source: HemOnctoday

You can get more details about Cardiology and its related topics from our Cardiology User Group.